This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to hepatitis C, inflammatory bowel disease, drug induced liver injury, nonalcoholic fatty liver disease, fecal microbiota transplantation and C. difficile. Notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad are also featured. In these briefings, ACG experts offer their perspectives on the significance of the findings in relation to the larger issues surrounding these GI-related topics as well as tips for clinicians and patients. Links to author commentary and the abstracts are available on this page for each abstract featured in the briefings.
Hepatitis C (HCV)
David E. Bernstein, MD, FACG and Paul Y. Kwo, MD, FACG provide insight on the following abstracts:
Oral 4 SVR12 of 99% Achieved With a Ribavirin-Free Regiment of ABT-450r Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients
Read author insight and access abstract
Oral 5 Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT -450/R/Ombitasvir, Dasabuvir and Ribavirin
Read author insight and access abstract
Access all ACG 2014 Press Briefings
Media Contact Info:
Members of the media who would like to arrange an interview with any of the experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.